Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company that operates with a fully integrated infrastructure encompassing commercial operations, supply chain management, regulatory affairs, medical affairs, and a dedicated salesforce. This robust framework supports the company's scalable business model across North America, allowing it to effectively bring a diverse portfolio of specialty and rare disease products to market. The company focuses on addressing various medical conditions, including those in allergy, dermatology, hematology, oncology, and rheumatology, which positions it for sustained growth over the next decade.

The product portfolio of Medexus includes both prescription and over-the-counter medications designed to meet the needs of patients and healthcare professionals. Notable products include Metoject® for rheumatoid arthritis, Rupall™ for allergies, and Oralvisc® for osteoarthritis, among others. The company emphasizes the importance of in-house expertise in areas such as sales, marketing, and regulatory compliance, which enhances its ability to drive organic growth and expand its product offerings. Medexus is also committed to responsible medication disposal through partnerships with health organizations, ensuring environmentally safe practices in the management of pharmaceuticals.

United States

Leading North American Specialty Pharmaceutical Company focused on hematology, rheumatology, auto-immune disease, specialty oncology and pediatrics.

Medexus Pharmaceuticals

Company Details